Last update 21 Sep 2026

Personalized Mutation-derived Tumor Vaccine(NovoCure)

Overview

Basic Info

Drug Type
Personalized antigen vaccine, Synthetic peptide vaccine, Therapeutic vaccine
Synonyms-
Target-
Action
modulators
Mechanism
Immunomodulators
Therapeutic Areas
NeoplasmsNervous System DiseasesOther Diseases
Active Indication
Glioblastoma Multiforme
Inactive Indication-
Originator Organization
NovoCure Ltd.NovoCure Ltd.
Active Organization
Oncovir, Inc.Oncovir, Inc.NovoCure Ltd.NovoCure Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

1
Clinical Trials associated with Personalized Mutation-derived Tumor Vaccine(NovoCure)
NCT03223103
/ Active, not recruitingPhase 1IIT
Phase I Study of Tumor Treatment Fields and a Personalized Mutation-derived Tumor Vaccine in Patients With Newly Diagnosed Glioblastoma (GCO 17-0566)
100 Clinical Results associated with Personalized Mutation-derived Tumor Vaccine(NovoCure)
Login to view more data
100 Translational Medicine associated with Personalized Mutation-derived Tumor Vaccine(NovoCure)
Login to view more data
100 Patents (Medical) associated with Personalized Mutation-derived Tumor Vaccine(NovoCure)
Login to view more data
100 Deals associated with Personalized Mutation-derived Tumor Vaccine(NovoCure)
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Glioblastoma MultiformePhase 1
United States
Oncovir, Inc.Oncovir, Inc.
01 Mar 2018
Glioblastoma MultiformePhase 1
United States
NovoCure Ltd.NovoCure Ltd.
01 Mar 2018
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
NCT03223103 (334, SITC2021)
Phase 1
Glioblastoma
tumor mutational burden | neoantigens
12
Personalized neoantigen vaccines
fsgvjaboxo(zxiwhkehjp) = The most common adverse events were injection site reactions and flu-like symptoms qzntuqegdp (mfirprwmhq )
Positive
10 Nov 2021
(TTFields)
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free